Switch to
Predicate | Object |
---|---|
rdf:type | |
lifeskim:mentions | |
pubmed:issue |
29
|
pubmed:dateCreated |
1978-9-25
|
pubmed:abstractText |
In a double-blind trial of patients with duodenal ulcer at three centres the healing rate after a four-week course of treatment (1 g cimetidine daily) was 79% (30 out of 38 patients), compared with 58% (23 out of 40 patients) on placebos. Cimetidine did not effect subjective symptoms or the need for antacids to relieve pain, except for a minor beneficial effect on diurnal ulcer symptoms during the second week of treatment. Results of long-term administration suggest that cimetidine at 400 mg daily prevent s relapses, but the possibility of an increased relapse rate after cimetidine withdrawal can not as yet be excluded.
|
pubmed:language |
ger
|
pubmed:journal | |
pubmed:citationSubset |
IM
|
pubmed:chemical | |
pubmed:status |
MEDLINE
|
pubmed:month |
Jul
|
pubmed:issn |
0012-0472
|
pubmed:author | |
pubmed:issnType |
Print
|
pubmed:day |
21
|
pubmed:volume |
103
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
1163-6
|
pubmed:dateRevised |
2006-11-15
|
pubmed:meshHeading |
pubmed-meshheading:668553-Adult,
pubmed-meshheading:668553-Aged,
pubmed-meshheading:668553-Ambulatory Care,
pubmed-meshheading:668553-Cimetidine,
pubmed-meshheading:668553-Double-Blind Method,
pubmed-meshheading:668553-Duodenal Ulcer,
pubmed-meshheading:668553-Female,
pubmed-meshheading:668553-Guanidines,
pubmed-meshheading:668553-Humans,
pubmed-meshheading:668553-Male,
pubmed-meshheading:668553-Middle Aged,
pubmed-meshheading:668553-Placebos,
pubmed-meshheading:668553-Recurrence
|
pubmed:year |
1978
|
pubmed:articleTitle |
[Cimetidine in the treatment of duodenal ulcer (author's transl)].
|
pubmed:publicationType |
Journal Article,
Clinical Trial,
English Abstract,
Randomized Controlled Trial,
Controlled Clinical Trial
|